2024-09-012025-08-312025-08-31false11507690PRUDENT PHARMA LIMITED2026-05-2686900falseiso4217:GBPxbrli:pure115076902024-08-31115076902025-08-31115076902024-09-012025-08-31115076902023-08-31115076902024-08-31115076902023-09-012024-08-3111507690bus:SmallEntities2024-09-012025-08-3111507690bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3111507690bus:FullAccounts2024-09-012025-08-3111507690bus:PrivateLimitedCompanyLtd2024-09-012025-08-3111507690core:WithinOneYear2025-08-3111507690core:AfterOneYear2025-08-3111507690core:WithinOneYear2024-08-3111507690core:AfterOneYear2024-08-3111507690core:ShareCapital2025-08-3111507690core:SharePremium2025-08-3111507690core:RevaluationReserve2025-08-3111507690core:OtherReservesSubtotal2025-08-3111507690core:RetainedEarningsAccumulatedLosses2025-08-3111507690core:ShareCapital2024-08-3111507690core:SharePremium2024-08-3111507690core:RevaluationReserve2024-08-3111507690core:OtherReservesSubtotal2024-08-3111507690core:RetainedEarningsAccumulatedLosses2024-08-3111507690core:LandBuildings2025-08-3111507690core:PlantMachinery2025-08-3111507690core:Vehicles2025-08-3111507690core:FurnitureFittings2025-08-3111507690core:OfficeEquipment2025-08-3111507690core:NetGoodwill2025-08-3111507690core:IntangibleAssetsOtherThanGoodwill2025-08-3111507690core:ListedExchangeTraded2025-08-3111507690core:UnlistedNon-exchangeTraded2025-08-3111507690core:LandBuildings2024-08-3111507690core:PlantMachinery2024-08-3111507690core:Vehicles2024-08-3111507690core:FurnitureFittings2024-08-3111507690core:OfficeEquipment2024-08-3111507690core:NetGoodwill2024-08-3111507690core:IntangibleAssetsOtherThanGoodwill2024-08-3111507690core:ListedExchangeTraded2024-08-3111507690core:UnlistedNon-exchangeTraded2024-08-3111507690core:LandBuildings2024-09-012025-08-3111507690core:PlantMachinery2024-09-012025-08-3111507690core:Vehicles2024-09-012025-08-3111507690core:FurnitureFittings2024-09-012025-08-3111507690core:OfficeEquipment2024-09-012025-08-3111507690core:NetGoodwill2024-09-012025-08-3111507690core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3111507690core:ListedExchangeTraded2024-09-012025-08-3111507690core:UnlistedNon-exchangeTraded2024-09-012025-08-3111507690core:MoreThanFiveYears2024-09-012025-08-3111507690core:Non-currentFinancialInstruments2025-08-3111507690core:Non-currentFinancialInstruments2024-08-3111507690dpl:CostSales2024-09-012025-08-3111507690dpl:DistributionCosts2024-09-012025-08-3111507690core:LandBuildings2024-09-012025-08-3111507690core:PlantMachinery2024-09-012025-08-3111507690core:Vehicles2024-09-012025-08-3111507690core:FurnitureFittings2024-09-012025-08-3111507690core:OfficeEquipment2024-09-012025-08-3111507690dpl:AdministrativeExpenses2024-09-012025-08-3111507690core:NetGoodwill2024-09-012025-08-3111507690core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3111507690dpl:GroupUndertakings2024-09-012025-08-3111507690dpl:ParticipatingInterests2024-09-012025-08-3111507690dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3111507690core:ListedExchangeTraded2024-09-012025-08-3111507690dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3111507690core:UnlistedNon-exchangeTraded2024-09-012025-08-3111507690dpl:CostSales2023-09-012024-08-3111507690dpl:DistributionCosts2023-09-012024-08-3111507690core:LandBuildings2023-09-012024-08-3111507690core:PlantMachinery2023-09-012024-08-3111507690core:Vehicles2023-09-012024-08-3111507690core:FurnitureFittings2023-09-012024-08-3111507690core:OfficeEquipment2023-09-012024-08-3111507690dpl:AdministrativeExpenses2023-09-012024-08-3111507690core:NetGoodwill2023-09-012024-08-3111507690core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3111507690dpl:GroupUndertakings2023-09-012024-08-3111507690dpl:ParticipatingInterests2023-09-012024-08-3111507690dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3111507690core:ListedExchangeTraded2023-09-012024-08-3111507690dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3111507690core:UnlistedNon-exchangeTraded2023-09-012024-08-3111507690core:NetGoodwill2025-08-3111507690core:IntangibleAssetsOtherThanGoodwill2025-08-3111507690core:LandBuildings2025-08-3111507690core:PlantMachinery2025-08-3111507690core:Vehicles2025-08-3111507690core:FurnitureFittings2025-08-3111507690core:OfficeEquipment2025-08-3111507690core:AfterOneYear2025-08-3111507690core:WithinOneYear2025-08-3111507690core:ListedExchangeTraded2025-08-3111507690core:UnlistedNon-exchangeTraded2025-08-3111507690core:ShareCapital2025-08-3111507690core:SharePremium2025-08-3111507690core:RevaluationReserve2025-08-3111507690core:OtherReservesSubtotal2025-08-3111507690core:RetainedEarningsAccumulatedLosses2025-08-3111507690core:NetGoodwill2024-08-3111507690core:IntangibleAssetsOtherThanGoodwill2024-08-3111507690core:LandBuildings2024-08-3111507690core:PlantMachinery2024-08-3111507690core:Vehicles2024-08-3111507690core:FurnitureFittings2024-08-3111507690core:OfficeEquipment2024-08-3111507690core:AfterOneYear2024-08-3111507690core:WithinOneYear2024-08-3111507690core:ListedExchangeTraded2024-08-3111507690core:UnlistedNon-exchangeTraded2024-08-3111507690core:ShareCapital2024-08-3111507690core:SharePremium2024-08-3111507690core:RevaluationReserve2024-08-3111507690core:OtherReservesSubtotal2024-08-3111507690core:RetainedEarningsAccumulatedLosses2024-08-3111507690core:NetGoodwill2023-08-3111507690core:IntangibleAssetsOtherThanGoodwill2023-08-3111507690core:LandBuildings2023-08-3111507690core:PlantMachinery2023-08-3111507690core:Vehicles2023-08-3111507690core:FurnitureFittings2023-08-3111507690core:OfficeEquipment2023-08-3111507690core:AfterOneYear2023-08-3111507690core:WithinOneYear2023-08-3111507690core:ListedExchangeTraded2023-08-3111507690core:UnlistedNon-exchangeTraded2023-08-3111507690core:ShareCapital2023-08-3111507690core:SharePremium2023-08-3111507690core:RevaluationReserve2023-08-3111507690core:OtherReservesSubtotal2023-08-3111507690core:RetainedEarningsAccumulatedLosses2023-08-3111507690core:AfterOneYear2024-09-012025-08-3111507690core:WithinOneYear2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3111507690core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3111507690core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3111507690core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3111507690core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3111507690core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3111507690bus:Director12024-09-012025-08-3111507690bus:Director22024-09-012025-08-31

PRUDENT PHARMA LIMITED

Registered Number
11507690
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

PRUDENT PHARMA LIMITED
Company Information
for the year from 1 September 2024 to 31 August 2025

Directors

Mr I Ahmed
Mrs K Ahmed

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

11507690 (England and Wales)
PRUDENT PHARMA LIMITED
Balance Sheet as at
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Investments31,508,5401,508,540
1,508,5401,508,540
Creditors amounts falling due within one year4(964,889)(909,429)
Net current assets (liabilities)(964,889)(909,429)
Total assets less current liabilities543,651599,111
Creditors amounts falling due after one year5(542,450)(591,754)
Net assets1,2017,357
Capital and reserves
Called up share capital100100
Profit and loss account1,1017,257
Shareholders' funds1,2017,357
The financial statements were approved and authorised for issue by the Board of Directors on 26 May 2026, and are signed on its behalf by:
Mr I Ahmed
Director
Registered Company No. 11507690
PRUDENT PHARMA LIMITED
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Investments
Investments in subsidiary undertakings are recognised at cost.
2.Average number of employees

20252024
Average number of employees during the year00
3.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 September 241,508,5401,508,540
At 31 August 251,508,5401,508,540
Net book value
At 31 August 251,508,5401,508,540
At 31 August 241,508,5401,508,540

Notes

1Investments in group undertakings and participating interests
4.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts44,17544,175
Amounts owed to related parties749,896645,678
Other creditors170,818219,576
Total964,889909,429
5.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts542,450591,754
Total542,450591,754
6.Related party transactions
Amounts owed to related parties of £749,896 (2024: £645,678) relates to Parklands (Northampton) Ltd. The directors are also the directors in this company. Other creditors of £170,818 (2024: £219,576) relates to the directors' current account which belongs to both the directors.